Company intelligence / Profile preview

ApiFix

Yokneam Illit, Israelapifix.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

The ApiFix MID-C system offers a minimally invasive, motion-preserving alternative to spinal fusion for select adolescent idiopathic scoliosis patients. Clinical results show reduced surgery time, blood loss, hospitalization, recovery time, and complication rates compared to traditional fusion or tethering. The device allows for post-operative adjustment and can be removed if needed.

Therapeutic areas: OtherRheumatology
Modalities: DeviceNon-pharmacological therapy
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on ApiFix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ApiFix.

Explore the full profile